| |
Latest 10 SEC filings (by transaction date) for FATE within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 25/24 | Mar 21/24 | Redmile Group, LLC | Indirect Ownership | Pre-Funded Warrants to Purchase Common Stock | A - Grant, award or other under Rule 16b-3(d) | 3,636,364 | $5.50 |
Mar 5/24 | Mar 4/24 | Dulac Edward J III | Direct Ownership | Common Stock | S - Open market or private sale | -2,447 | $7.77 |
Feb 2/24 | Feb 1/24 | Wolchko J Scott | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 500,000 | |
Feb 2/24 | Feb 1/24 | Tahl Cindy | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 425,000 | |
Feb 2/24 | Feb 1/24 | Dulac Edward J III | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 425,000 | |
Feb 2/24 | Feb 1/24 | Valamehr Bahram | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 450,000 | |
Jan 30/24 | Jan 29/24 | Dulac Edward J III | Direct Ownership | Common Stock | S - Open market or private sale | -1,849 | $5.00 |
Jan 10/24 | Jan 9/24 | Tahl Cindy | Direct Ownership | Common Stock | S - Open market or private sale | -10,874 | $4.37 |
Jan 10/24 | Jan 9/24 | Valamehr Bahram | Direct Ownership | Common Stock | S - Open market or private sale | -11,271 | $4.38 |
Jan 10/24 | Jan 9/24 | Wolchko J Scott | Direct Ownership | Common Stock | S - Open market or private sale | -14,391 | $4.37 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for FATE within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 25/24 | Mar 21/24 | Redmile Group, LLC | Indirect Ownership | Pre-Funded Warrants to Purchase Common Stock | A - Grant, award or other under Rule 16b-3(d) | 3,636,364 | $5.50 |
Mar 5/24 | Mar 4/24 | Dulac Edward J III | Direct Ownership | Common Stock | S - Open market or private sale | -2,447 | $7.77 |
Feb 2/24 | Feb 1/24 | Wolchko J Scott | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 500,000 | |
Feb 2/24 | Feb 1/24 | Tahl Cindy | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 425,000 | |
Feb 2/24 | Feb 1/24 | Dulac Edward J III | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 425,000 | |
Feb 2/24 | Feb 1/24 | Valamehr Bahram | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 450,000 | |
Jan 30/24 | Jan 29/24 | Dulac Edward J III | Direct Ownership | Common Stock | S - Open market or private sale | -1,849 | $5.00 |
Jan 10/24 | Jan 9/24 | Tahl Cindy | Direct Ownership | Common Stock | S - Open market or private sale | -10,874 | $4.37 |
Jan 10/24 | Jan 9/24 | Valamehr Bahram | Direct Ownership | Common Stock | S - Open market or private sale | -11,271 | $4.38 |
Jan 10/24 | Jan 9/24 | Wolchko J Scott | Direct Ownership | Common Stock | S - Open market or private sale | -14,391 | $4.37 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |